Clinical Trial Update: Estrogen Replacement and Atherosclerosis (ERA) in Older Women [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating estrogen replacement for atherosclerosis in older women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Coronary Arteriosclerosis
• Coronary Artery Disease
• Heart Diseases
• Myocardial Ischemia
• Postmenopause

Drugs mentioned

• Estrogen Replacement Therapy (estrogen replacement therapy)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Coronary Arteriosclerosis | Phase 3 | Status: COMPLETED